Triple
T22492442
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Amphotericin B |
E556051
|
entity |
| Predicate | liposomalFormulationsHaveProperty |
P143829
|
FINISHED |
| Object | reduced nephrotoxicity compared with conventional formulation |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: reduced nephrotoxicity compared with conventional formulation | Statement: [Amphotericin B, liposomalFormulationsHaveProperty, reduced nephrotoxicity compared with conventional formulation]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: liposomalFormulationsHaveProperty Context triple: [Amphotericin B, liposomalFormulationsHaveProperty, reduced nephrotoxicity compared with conventional formulation]
-
A.
formulationFeature
chosen
Indicates a relationship where a formulation possesses, includes, or is characterized by a particular feature or property.
-
B.
hasBioavailability
Indicates that a substance has a specified degree or measure of bioavailability, i.e., the proportion that enters circulation and can have an active effect.
-
C.
isProdrugOf
Indicates that one substance is a precursor form that is metabolized in the body to produce the active form of another substance.
-
D.
formulatedIn
Indicates that something was created, developed, or expressed within a particular context, place, or framework.
-
E.
isExtendedReleaseFormulationOf
Indicates that one pharmaceutical formulation is an extended-release version of another, designed to release the active ingredient more slowly over time.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e11e5445bc8190b6a9481926db3355 |
completed | April 16, 2026, 5:37 p.m. |
| NER | Named-entity recognition | batch_69f15cb01b3481908a9143503b75167f |
completed | April 29, 2026, 1:19 a.m. |
| PD | Predicate disambiguation | batch_69e898be31448190be5ae7f5656f0497 |
completed | April 22, 2026, 9:45 a.m. |
Created at: April 16, 2026, 8:49 p.m.